"Endemic Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The constant presence of diseases or infectious agents within a given geographic area or population group. It may also refer to the usual prevalence of a given disease with such area or group. It includes holoendemic and hyperendemic diseases. A holoendemic disease is one for which a high prevalent level of infection begins early in life and affects most of the child population, leading to a state of equilibrium such that the adult population shows evidence of the disease much less commonly than do children (malaria in many communities is a holoendemic disease). A hyperendemic disease is one that is constantly present at a high incidence and/or prevalence rate and affects all groups equally. (Last, A Dictionary of Epidemiology, 3d ed, p53, 78, 80)
Descriptor ID |
D019353
|
MeSH Number(s) |
N06.850.392
|
Concept/Terms |
Endemic Diseases- Endemic Diseases
- Disease, Endemic
- Diseases, Endemic
- Endemic Disease
|
Below are MeSH descriptors whose meaning is more general than "Endemic Diseases".
Below are MeSH descriptors whose meaning is more specific than "Endemic Diseases".
This graph shows the total number of publications written about "Endemic Diseases" by people in this website by year, and whether "Endemic Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2011 | 1 | 0 | 1 |
2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Endemic Diseases" by people in Profiles.
-
Preparedness for malaria elimination in the wake of climate change in the State of Uttarakhand (India). J Vector Borne Dis. 2019 Jan-Mar; 56(1):46-52.
-
Duration of protection after infant hepatitis B vaccination series. Pediatrics. 2014 Jun; 133(6):e1500-7.
-
Preclinical prophylactic efficacy testing of Sm-p80-based vaccine in a nonhuman primate model of Schistosoma mansoni infection and immunoglobulin G and E responses to Sm-p80 in human serum samples from an area where schistosomiasis is endemic. J Infect Dis. 2011 Nov; 204(9):1437-49.